Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation for Steroid-Resistant or Relapsed Immune Thrombocytopenia
NCT07733037Phase 2Active, not recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in immune thrombocytopenia (ITP) comparing Fecal microbiota transplantation group with Placebo group (2 arms). Primary endpoint: Overall Response Rate at 12 weeks. Started Jan 2026; status: active, not recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT07733037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07733037.